All Stories

  1. Diuretics and ultrafiltration in heart failure
  2. Indications for and Timing of Initiation of KRT
  3. What every Intensivist should know about COVID-19 associated acute kidney injury
  4. Extracorporeal Treatment for Chloroquine, Hydroxychloroquine, and Quinine Poisoning: Systematic Review and Recommendations from the EXTRIP Workgroup
  5. Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
  6. Health-related quality of life in survivors of septic shock: 6-month follow-up from the ADRENAL trial
  7. Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury
  8. Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock
  9. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study
  10. Parenteral thiamine for prevention and treatment of delirium in critically ill adults: a systematic review protocol
  11. Fluid removal associates with better outcomes in critically ill patients receiving continuous renal replacement therapy: a cohort study
  12. Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
  13. Roles of angiotensin II as vasopressor in vasodilatory shock
  14. Extracorporeal Blood Purification and Organ Support in the Critically Ill Patient during COVID-19 Pandemic: Expert Review and Recommendation
  15. Acute kidney injury in critically ill cancer patients is associated with mortality: A retrospective analysis
  16. Sepsis at ICU admission does not decrease 30-day survival in very old patients: a post-hoc analysis of the VIP1 multinational cohort study
  17. Fluid management knowledge in hospital physicians: ‘Greenshoots’ of improvement but still a cause for concern
  18. Optimal management of acute kidney injury in critically ill patients with invasive fungal infections being treated with liposomal amphotericin B
  19. Renal replacement anticoagulant management: Protocol and analysis plan for an observational comparative effectiveness study of linked data sources
  20. A Multinational Observational Study Exploring Adherence With the Kidney Disease
  21. Pro: We Should Stop ACE Inhibitors Early Before Cardiac Surgery to Prevent Postoperative AKI
  22. Biomarker-guided implementation of the KDIGO guidelines to reduce the occurrence of acute kidney injury in patients after cardiac surgery (PrevAKI-multicentre): protocol for a multicentre, observational study followed by randomised controlled feasibili...
  23. The Effect of Renal Replacement Therapy and Antibiotic Dose on Antibiotic Concentrations in Critically Ill Patients: Data From the Multinational Sampling Antibiotics in Renal Replacement Therapy Study
  24. Protocol and statistical analysis plan for the REstricted fluid therapy VERsus Standard trEatment in Acute Kidney Injury—REVERSE‐AKI randomized controlled pilot trial
  25. Identification and validation of biomarkers of persistent acute kidney injury: the RUBY study
  26. Angiotensin I and angiotensin II concentrations and their ratio in catecholamine-resistant vasodilatory shock
  27. Acute kidney injury as a risk factor of hyperactive delirium: A case control study
  28. Net Ultrafiltration Prescription and Practice Among Critically Ill Patients Receiving Renal Replacement Therapy
  29. Creatinine: From physiology to clinical application
  30. Micronutrients in critically ill patients with severe acute kidney injury – a prospective study
  31. A narrative review of the impact of surgery and anaesthesia on acute kidney injury
  32. Long‐term patient‐important outcomes after septic shock: A protocol for 1‐year follow‐up of the CLASSIC trial
  33. Lung–kidney interactions in critically ill patients: consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup
  34. Cumulative fluid accumulation is associated with the development of acute kidney injury and non-recovery of renal function: a retrospective analysis
  35. Report of the first AKI Round Table meeting: an initiative of the ESICM AKI Section
  36. How much centralization of critical care services in the era of telemedicine?
  37. Optimizing renal replacement therapy for patients who need extracorporeal membrane oxygenation: cross-talk between two organ support machines
  38. Effect of high-dose vitamin D3 on 28-day mortality in adult critically ill patients with severe vitamin D deficiency: a study protocol of a multicentre, placebo-controlled double-blind phase III RCT (the VITDALIZE study)
  39. Epidemiology of intra-abdominal infection and sepsis in critically ill patients: “AbSeS”, a multinational observational cohort study and ESICM Trials Group Project
  40. Acute Kidney Injury and Septic Shock—Defined by Updated Sepsis-3 Criteria in Critically Ill Patients
  41. Fluid Management in Acute Kidney Injury
  42. Vasopressor Therapy and Blood Pressure Management in the Setting of Acute Kidney Injury
  43. Less is more: ten reasons for considering to discontinue unproven interventions
  44. Renal replacement therapy for acute kidney injury in intensive care
  45. Conservative vs liberal fluid therapy in septic shock (CLASSIC) trial—Protocol and statistical analysis plan
  46. Evaluating Renal Stress Using Pharmacokinetic Urinary Biomarker Data in Critically Ill Patients Receiving Vancomycin and/or Piperacillin–Tazobactam: A Secondary Analysis of the Multicenter Sapphire Study
  47. Sensitivity to angiotensin II dose in patients with vasodilatory shock: a prespecified analysis of the ATHOS-3 trial
  48. Changes in critically ill cancer patients’ short-term outcome over the last decades: results of systematic review with meta-analysis on individual data
  49. Quality Improvement Goals for Acute Kidney Injury
  50. Renal function after out-of-hospital cardiac arrest; the influence of temperature management and coronary angiography, a post hoc study of the target temperature management trial
  51. How to feed a patient with acute kidney injury
  52. Broad spectrum vasopressors: a new approach to the initial management of septic shock?
  53. Cumulative Prognostic Score Predicting Mortality in Patients Older Than 80 Years Admitted to the ICU
  54. Statement paper on diversity for the European Society of Intensive Care Medicine (ESICM)
  55. Distance between the tips of central venous catheters does not depend on same or opposite site access
  56. Diagnosis of death using neurological criteria in adult patients on extracorporeal membrane oxygenation: Development of UK guidance
  57. Challenges in the management of septic shock: a narrative review
  58. 10 myths about frusemide
  59. Ten tips to manage renal transplant recipients
  60. Serial Urinary Tissue Inhibitor of Metalloproteinase-2 and Insulin-Like Growth Factor-Binding Protein 7 and the Prognosis for Acute Kidney Injury over the Course of Critical Illness
  61. Continuous renal replacement therapy during extracorporeal membrane oxygenation
  62. Influence of neutropenia on mortality of critically ill cancer patients: results of a meta-analysis on individual data
  63. Risk prediction for acute kidney injury in acute medical admissions in the UK
  64. Effect of Human Recombinant Alkaline Phosphatase on 7-Day Creatinine Clearance in Patients With Sepsis-Associated Acute Kidney Injury
  65. Angiotensin in ECMO patients with refractory shock
  66. Unrecognised myocardial infarction and its relationship to outcome in critically ill patients with cardiovascular disease
  67. Correction to: Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit
  68. suPAR as a marker of infection in acute kidney injury – a prospective observational study
  69. MAP of 65: target of the past?
  70. Cardiac and Vascular Surgery–Associated Acute Kidney Injury: The 20th International Consensus Conference of the ADQI (Acute Disease Quality Initiative) Group
  71. Low-molecular-weight heparin venous thromboprophylaxis in critically ill patients with renal dysfunction: A subgroup analysis of the PROTECT trial
  72. Outcomes in Patients with Vasodilatory Shock and Renal Replacement Therapy Treated with Intravenous Angiotensin II
  73. Withholding or withdrawing of life-sustaining therapy in older adults (≥ 80 years) admitted to the intensive care unit
  74. Exploring the impact of using measured or estimated values for height and weight on the relationship between BMI and acute hospital mortality
  75. Pragmatic studies for acute kidney injury: Consensus report of the Acute Disease Quality Initiative (ADQI) 19 Workgroup
  76. Angiotensin in Critical Care
  77. Erratum to “Intraoperative permissive oliguria – how much is too much?” [Br J Anaesth 119 (2017) 1075–1077]
  78. Kinetics of Urinary Cell Cycle Arrest Markers for Acute Kidney Injury Following Exposure to Potential Renal Insults
  79. Techniques and Modalities of Continuous Renal Replacement Therapy
  80. The Burden of Acute Kidney Injury and Related Financial Issues
  81. Drug management in acute kidney disease - Report of the Acute Disease Quality Initiative XVI meeting
  82. Intraoperative permissive oliguria – how much is too much?
  83. The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
  84. Correction to: The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study
  85. The effect of regional citrate anti-coagulation on the coagulation system in critically ill patients receiving continuous renal replacement therapy for acute kidney injury - an observational cohort study
  86. Characteristics and Outcome of Cancer Patients Admitted to the ICU in England, Wales, and Northern Ireland and National Trends Between 1997 and 2013*
  87. The impact of frailty on ICU and 30-day mortality and the level of care in very elderly patients (≥ 80 years)
  88. Pathophysiology of AKI
  89. Early troponin I in critical illness and its association with hospital mortality: a cohort study
  90. Angiotensin II for the Treatment of Vasodilatory Shock
  91. Elevated preoperative heart rate is associated with cardiopulmonary and autonomic impairment in high-risk surgical patients
  92. Renal Support for Acute Kidney Injury in the Developing World
  93. Vitamin D levels in critically ill patients with acute kidney injury: a protocol for a prospective cohort study (VID-AKI)
  94. Cardiac Troponin Release is Associated with Biomarkers of Inflammation and Ventricular Dilatation During Critical Illness
  95. Prevention of acute kidney injury and protection of renal function in the intensive care unit: update 2017
  96. Low mean perfusion pressure is a risk factor for progression of acute kidney injury in critically ill patients – A retrospective analysis
  97. Renal recovery after acute kidney injury
  98. Diagnostic work-up and specific causes of acute kidney injury
  99. Have renal biomarkers failed in acute kidney injury? Yes
  100. Cardiac biomarkers are associated with maximum stage of acute kidney injury in critically ill patients: a prospective analysis
  101. The AKI glossary
  102. Current state of the art for renal replacement therapy in critically ill patients with acute kidney injury
  103. Acute kidney disease and renal recovery: consensus report of the Acute Disease Quality Initiative (ADQI) 16 Workgroup
  104. Predictions are difficult…especially about AKI
  105. The intensive care medicine agenda on acute kidney injury
  106. Lymphocyte Function in Human Acute Kidney Injury
  107. In critically ill patients with acute kidney injury stage 2, early initiation of renal replacement therapy is associated with reduced 90-day mortality compared to delayed initiation
  108. Intravascular versus surface cooling for targeted temperature management after out-of-hospital cardiac arrest – an analysis of the TTM trial data
  109. Nomenclature for renal replacement therapy and blood purification techniques in critically ill patients: practical applications
  110. Nomenclature for renal replacement therapy in acute kidney injury: basic principles
  111. Short-term and medium-term survival of critically ill patients with solid tumours admitted to the intensive care unit: a retrospective analysis
  112. Acute kidney injury 2016: diagnosis and diagnostic workup
  113. Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock
  114. The two sides of creatinine: both as bad as each other?
  115. Goal-directed therapy and acute kidney injury: as good as it gets?
  116. The Dose Response Multicentre Investigation on Fluid Assessment (DoReMIFA) in critically ill patients
  117. Fatal cardiovascular instability secondary to hypercalcaemia and intracellular calcium deposition complicating T-cell leukaemia-lymphoma
  118. Diuretics in critical illness
  119. Anaemia is not a risk factor for progression of acute kidney injury: a retrospective analysis
  120. Incidence of tuberculosis is high in chronic kidney disease patients in South East England and drug resistance common
  121. Patient Selection and Timing of Continuous Renal Replacement Therapy
  122. Timing of Renal Replacement Therapy in Acute Kidney Injury
  123. Fluid overload and acute kidney injury: cause or consequence?
  124. Citrate anticoagulation for CRRT: don’t always trust the postfilter iCa results!
  125. Fenoldopam to prevent acute kidney injury after major surgery—a systematic review and meta-analysis
  126. Ionized calcium measurements during regional citrate anticoagulation in CRRT: we need better blood gas analyzers
  127. Increased Fluid Administration After Early Acute Kidney Injury is Associated with Less Renal Recovery
  128. Revised algorithm for heparin anticoagulation during continuous renal replacement therapy
  129. Is prolonged infusion of piperacillin/tazobactam and meropenem in critically ill patients associated with improved pharmacokinetic/pharmacodynamic and patient outcomes? An observation from the Defining Antibiotic Levels in Intensive care unit patients ...
  130. Fluid Composition and Clinical Effects
  131. Recognition and management of acute kidney injury in hospitalised patients can be partially improved with the use of a care bundle
  132. Competing Risk Analysis for Evaluation of Dalteparin Versus Unfractionated Heparin for Venous Thromboembolism in Medical-Surgical Critically Ill Patients
  133. AKI and haemodynamics
  134. Mood and illness experiences of adults with cystinosis
  135. Failure of Anticoagulant Thromboprophylaxis
  136. Timing of Renal Replacement Therapy
  137. Acute Kidney Injury Biomarkers
  138. Long-term sequelae from acute kidney injury: potential mechanisms for the observed poor renal outcomes
  139. Dose of Renal Replacement Therapy in AKI
  140. The definition of acute kidney injury and its use in practice
  141. Diagnosis of acute kidney injury
  142. Biomarkers for AKI improve clinical practice: no
  143. Novel risk factors for acute kidney injury
  144. Indications and management of mechanical fluid removal in critical illness
  145. Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study
  146. Nonleg Venous Thrombosis in Critically Ill Adults
  147. Prevention, detection and management of acute kidney injury: concise guideline
  148. DALI: Defining Antibiotic Levels in Intensive Care Unit Patients: Are Current  -Lactam Antibiotic Doses Sufficient for Critically Ill Patients?
  149. Correction of Hyper- and Hyponatraemia during Continuous Renal Replacement Therapy
  150. Echocardiography Predicts Major Adverse Cardiovascular Events after Renal Transplantation
  151. Measuring biomarkers of acute kidney injury during renal replacement therapy: wisdom or folly?
  152. A prospective study of the impact of serial troponin measurements on the diagnosis of myocardial infarction and hospital and six-month mortality in patients admitted to ICU with non-cardiac diagnoses
  153. Targeted Temperature Management at 33°C versus 36°C after Cardiac Arrest
  154. Genome-Wide Sequencing of Cellular microRNAs Identifies a Combinatorial Expression Signature Diagnostic of Sepsis
  155. Restrictive Versus Liberal Transfusion Strategies for Older Mechanically Ventilated Critically Ill Patients
  156. Thrombocytopenia in Critically Ill Patients Receiving Thromboprophylaxis
  157. Heparin-Induced Thrombocytopenia in Medical Surgical Critical Illness
  158. Acute kidney injury: summary of NICE guidance
  159. Risk factors and impact of major bleeding in critically ill patients receiving heparin thromboprophylaxis
  160. Acute kidney injury after cardiac surgery according to Risk/Injury/Failure/Loss/End-stage, Acute Kidney Injury Network, and Kidney Disease: Improving Global Outcomes classifications
  161. Predicting the development of acute kidney injury in liver cirrhosis - an analysis of glomerular filtration rate, proteinuria and kidney injury biomarkers
  162. RCPE UK Consensus Conference Statement: Management of acute kidney injury: the role
  163. Rates and determinants of informed consent: A case study of an international thromboprophylaxis trial
  164. Outcomes of Chronic Hemodialysis Patients in the Intensive Care Unit
  165. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury
  166. Improved Outcome of Severe Acute Pancreatitis in the Intensive Care Unit
  167. Retrospective analysis of outcome of women with breast or gynaecological cancer in the intensive care unit
  168. Beyond the Randomized Clinical Trial: Citrate for Continuous Renal Replacement Therapy in Clinical Practice
  169. Maintaining Normal Levels of Ionized Calcium during Citrate-Based Renal Replacement Therapy Is Associated with Stable Parathyroid Hormone Levels
  170. Letters to the editor
  171. Intravenous fluid use in the acutely unwell adult medical inpatient: improving practice through a clinical audit process
  172. Faculty of 1000 evaluation for Clinical factors associated with initiation of renal replacement therapy in critically ill patients with acute kidney injury-A prospective multicenter observational study.
  173. Successful management of severe hyponatraemia during continuous renal replacement therapy
  174. Renal replacement therapy in critically ill patients with acute kidney injury--when to start
  175. Care of the Critically Ill Emergency Department Patient with Acute Kidney Injury
  176. Clinical review: Biomarkers of acute kidney injury: where are we now?
  177. Bench-to-bedside review: Citrate for continuous renal replacement therapy, from science to practice
  178. Impact of different types of organ failure on outcome in intensive care unit patients with acute kidney injury
  179. Choice of Renal Replacement Therapy and Role of Haemodialysis in the Intensive Care Unit
  180. Role of Implantable Cardioverter Defibrillators for Dialysis Patients
  181. Challenges of defining acute kidney injury
  182. Guidelines for the prevention and management of Mycobacterium tuberculosis infection and disease in adult patients with chronic kidney disease
  183. ICU and 6-month outcome of oncology patients in the intensive care unit
  184. Intensity of Continuous Renal-Replacement Therapy
  185. Management of sodium disorders during continuous haemofiltration
  186. Heparin algorithm for anticoagulation during continuous renal replacement therapy
  187. Effect of "collaborative requesting" on consent rate for organ donation: randomised controlled trial (ACRE trial)
  188. Response to ‘Could N-terminal pro-BNP be a useful marker for prediction of cardiac arrests in hemodialysis patients?’
  189. Correlation between parameters at initiation of renal replacement therapy and outcome in patients with acute kidney injury
  190. Cardiac arrests in hemodialysis patients: An ongoing challenge
  191. Acute Renal Failure in the Surgical Patient
  192. Renal failure in the intensive care unit: acute kidney injury compared to end-stage renal failure
  193. Correlation between the AKI classification and outcome
  194. Acute kidney injury on admission to the intensive care unit: where to go from here?
  195. The RIFLE criteria: Are the foundations robust?
  196. Frusemide Administration in Critically Ill Patients by Continuous Compared to Bolus Therapy
  197. Acute kidney injury in the intensive care unit according to RIFLE*
  198. Octreotide for relapsing sulfonylurea-induced hypoglycemia in a dialysis patient
  199. ACUTE RENAL FAILURE IN ICU - EVALUATION OF THE RIFLE CLASSIFICATION.
  200. Differential inducible nitric oxide synthase activity in circulating neutrophils vs. mononuclears of septic shock patients
  201. Prognosis of acute renal failure: an evaluation of proposed consensus criteria
  202. Pre-existing renal failure doubles 30-day mortality after heart transplantation
  203. Metabolic alkalosis in patients with renal failure
  204. Haemodialysis patients' views on their resuscitation status
  205. A 67‐year‐old kidney transplant patient with headache of uncertain origin
  206. Prophylaxis of cytomegalovirus infection in renal transplantation
  207. Coma mimicking brain death following baclofen overdose
  208. Acute renal failure following cardiopulmonary bypass: a changing picture
  209. Sedation in the Intensive Care Unit
  210. Lipid Profiles in Patients with Atherosclerotic Renal Artery Stenosis
  211. Effect of continuous haemofiltration on essential micronutrient levels
  212. Faculty of 1000 evaluation for Preoperative Statin Use and Postoperative Acute Kidney Injury.
  213. Faculty of 1000 evaluation for The fallacy of the BUN:creatinine ratio in critically ill patients.
  214. Faculty of 1000 evaluation for Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials.
  215. Faculty of 1000 evaluation for Efficacy and safety of regional citrate anticoagulation in critically ill patients undergoing continuous renal replacement therapy.
  216. Faculty of 1000 evaluation for Regional citrate versus systemic heparin for anticoagulation in critically ill patients on continuous venovenous haemofiltration: a prospective randomized multicentre trial.
  217. Faculty of 1000 evaluation for Sodium bicarbonate infusion to reduce cardiac surgery-associated acute kidney injury: a phase II multicenter double-blind randomized controlled trial.
  218. Faculty of 1000 evaluation for Prophylactic perioperative sodium bicarbonate to prevent acute kidney injury following open heart surgery: a multicenter double-blinded randomized controlled trial.
  219. Faculty of 1000 evaluation for Are Autopsy Findings Still Relevant to the Management of Critically Ill Patients in the Modern Era?
  220. Faculty of 1000 evaluation for Effect of the intensity of continuous renal replacement therapy in patients with sepsis and acute kidney injury: a single-center randomized clinical trial.